Insider · CIK 0001862144
Sherry Aulin
Files at XENE (Xenon Pharmaceuticals Inc.). First filing Dec 19, 2024, latest Dec 19, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XENE: Xenon Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | XENEsell Xenon Pharmaceuticals Inc. | $771k 18,709 shares | -260% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +9,334 | $9.44 | $88k | 9,334 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | FTax withholding Common Shares | -2,135 | $41.28 | $88k | 7,199 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares | -7,199 | $41.23 | $297k | 0 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +16,000 | $11.58 | $185k | 16,000 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | FTax withholding Common Shares | -4,490 | $41.28 | $185k | 11,510 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares | -11,510 | $41.19 | $474k | 0 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Stock Option (Right to Buy)derivative | -9,334 | $0.00 | $0 | 0 | Dec 19, 2024 |
| Dec 18, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Stock Option (Right to Buy)derivative | -16,000 | $0.00 | $0 | 6,000 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.